YOLFTbeta
Porton Fine Chemicals Ltd

Porton Fine Chemicals Ltd

300363 · SHE · Healthcare / Drug Manufacturers - Specialty & Generic

21.95CNY-0.71 (-3.13%)

Price History

Full chart

Market Stats

Previous Close22.66
Open22.55
Day Range21.87 – 22.74
52-Week Range13.24 – 30.27
Volume11.22M
Market Cap13.35B
P/E (TTM)0.00
Forward P/E0.00
EPS-0.28
Dividend Yield0.37%
Beta0.52
50-Day Avg20.31
200-Day Avg20.49

About

Porton Pharma Solutions Ltd. provides contract development and manufacturing organization (CDMO) solutions for small molecules, tides, biologics, and conjugates from pre-clinical to commercial in China and internationally. It has a strategic collaboration with Aojin Life Sciences to advance XDC conjugate drugs; and strategic partnership with Dragon Sail Pharmaceutical to build a new ecosystem for ADC drug development, production, and supply chain. It also offers crystallization, bio catalysis, metal catalysis, flow chemistry, prep-chromatography, and milling. Porton Pharma Solutions Ltd. was formerly known as Porton Fine Chemicals Ltd. and changed its name to Porton Pharma Solutions Ltd. in January 2018. The company was incorporated in 2005 and is headquartered in Chongqing, China.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Nianfeng Ju
  • Employees4.40K
  • HeadquartersNo.7, Yuntu Road, Chongqing, China, 400714, China
  • Websitehttps://www.portonpharma.com

Leadership

  • Mr. Nianfeng JuChairman & GM · b. 1972
  • Mr. Hui ChenDeputy GM & CFO · b. 1979
  • Mr. Yinchun BaiSenior Deputy GM, COO & Employee Representative Director · b. 1973
  • Ms. Wei PiDeputy GM & Secretary of the Board of Directors · b. 1987
  • Mr. Po ZhuDeputy General Manager · b. 1970
  • Mr. Qi ChenDeputy General Manager · b. 1977
  • Ya Qian RuanAccounting Supervisor

Financials

Income Statement

Currency: CNY2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue288.54M455.83M552.57M689.88M734.36M987.26M1.02B1.33B1.18B1.18B1.55B2.07B3.11B7.03B3.67B3.01B3.42B
Growth (%)-+57.98%+21.22%+24.85%+6.45%+34.44%+3.44%+29.91%-10.74%+0.07%+30.93%+33.56%+49.87%+126.55%-47.87%-17.87%+13.54%
Cost of Revenue183.98M318.30M366.73M460.89M454.56M636.43M693.80M826.58M755.49M794.95M1.00B1.24B1.84B3.40B2.23B2.31B2.40B
Gross Profit104.56M137.53M185.83M228.99M279.81M350.83M327.41M500.05M428.60M389.92M549.87M834.99M1.26B3.64B1.44B702.62M1.02B
Gross Margin36.24%30.17%33.63%33.19%38.10%35.54%32.06%37.69%36.20%32.91%35.45%40.30%40.64%51.69%39.19%23.33%29.94%
Operating Expense58.93M78.49M111.10M117.09M163.92M208.12M198.33M304.38M314.04M235.96M355.18M482.76M696.45M1.37B1.17B1.05B812.82M
Operating Income45.62M59.04M74.73M111.90M115.89M142.71M129.07M195.67M114.56M153.96M194.69M352.24M565.60M2.27B268.91M-342.50M211.03M
Operating Margin15.81%12.95%13.52%16.22%15.78%14.45%12.64%14.75%9.68%12.99%12.55%17.00%18.21%32.20%7.33%-11.37%6.17%
EBITDA60.84M76.30M96.44M126.54M146.51M185.32M205.13M311.77M285.67M236.59M295.37M497.81M719.86M2.45B580.68M95.90M559.37M
EBITDA Margin21.09%16.74%17.45%18.34%19.95%18.77%20.09%23.50%24.13%19.97%19.04%24.03%23.18%34.86%15.83%3.18%16.36%
Net Income30.23M43.05M62.40M80.27M100.20M125.49M110.39M171.19M107.45M124.49M185.55M324.42M523.92M2.01B266.86M-287.75M96.34M
Net Income Margin10.48%9.44%11.29%11.64%13.64%12.71%10.81%12.90%9.07%10.51%11.96%15.66%16.87%28.51%7.28%-9.55%2.82%
R&D-17.83M22.45M33.39M40.99M42.55M50.34M72.60M75.33M76.20M122.55M157.84M263.82M519.51M452.23M338.49M267.58M
R&D as % of Total Revenue-3.91%4.06%4.84%5.58%4.31%4.93%5.47%6.36%6.43%7.90%7.62%8.50%7.38%12.33%11.24%7.82%
Interest Expense7.02M3.97M4.77M9.03M6.44M17.15M30.50M40.33M50.41M63.95M43.41M25.69M23.20M34.45M46.68M63.69M50.48M
Interest Expense % of Total Revenue2.43%0.87%0.86%1.31%0.88%1.74%2.99%3.04%4.26%5.40%2.80%1.24%0.75%0.49%1.27%2.11%1.48%

Balance Sheet

Currency: CNY2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets304.55M460.41M574.32M791.08M948.09M1.85B2.38B2.87B2.85B4.37B3.96B4.50B6.56B10.14B9.38B8.82B8.55B
Total Liabilities222.95M297.20M328.30M463.32M519.67M980.53M1.20B1.50B1.40B1.49B891.16M1.10B2.38B3.67B3.28B3.40B3.05B
Total Equity78.12M164.28M247.53M328.45M428.53M810.81M1.12B1.28B1.38B2.88B3.07B3.39B3.98B6.00B5.80B5.20B5.35B
Cash53.37M108.81M122.67M137.84M88.83M290.85M109.25M458.56M306.56M1.49B1.17B1.26B1.22B2.85B1.97B1.47B1.13B
Total Debt91.23M130.61M148.39M196.73M225.41M468.89M779.41M1.04B958.00M1.15B347.37M412.64M740.77M923.77M1.71B1.57B-
Net Debt37.86M21.79M25.72M58.89M136.58M178.03M670.16M581.06M651.44M-337.43M-827.31M-849.41M-476.10M-1.93B242.94M96.47M-

Cash Flow

Currency: CNY2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow31.99M35.75M65.43M114.21M114.05M121.92M112.31M285.33M289.46M193.62M351.37M504.37M480.17M2.56B629.06M405.53M757.01M
Investing Cash Flow-7.41M-73.47M-81.97M-138.58M-184.04M-340.71M-504.17M-197.77M-317.69M-655.92M174.55M-429.26M-916.17M-1.44B-1.11B-499.95M-
Financing Cash Flow18.12M96.33M35.78M34.05M17.84M420.26M213.88M256.57M-137.51M1.52B-804.81M51.95M350.22M260.84M-128.54M-413.74M-
Capital Expenditure2.87M34.85M81.48M130.51M186.26M336.96M424.03M188.57M158.67M168.13M175.06M393.97M776.97M1.17B1.13B490.58M292.57M
Free Cash Flow29.11M900.33K-16.05M-16.30M-72.21M-215.03M-311.72M96.76M130.79M25.49M176.32M110.40M-296.80M1.39B-500.81M-85.06M464.45M
Dividends Paid5.57M4.09M4.72M9.35M8.90M26.91M47.82M55.83M76.03M74.35M25.11M55.77M65.39M105.02M626.57M301.50M30.11M
FCF to OCF91.02%2.52%-24.53%-14.27%-63.31%-176.37%-277.55%33.91%45.18%13.17%50.18%21.89%-61.81%54.25%-79.61%-20.97%61.35%
Dividend Paid to FCF19.13%454.83%-29.41%-57.37%-12.33%-12.51%-15.34%57.70%58.13%291.67%14.24%50.51%-22.03%7.55%-125.11%-354.47%6.48%

Earnings

Report DateMar 31, 2014Aug 19, 2014Oct 24, 2014Feb 16, 2015Apr 22, 2015Aug 29, 2015Oct 26, 2015Feb 23, 2016Apr 25, 2016Aug 24, 2016Oct 26, 2016Feb 23, 2017Apr 26, 2017Aug 25, 2017Oct 27, 2017Apr 24, 2018Aug 24, 2018Oct 26, 2018Apr 24, 2019Jul 30, 2019Oct 29, 2019Feb 25, 2020Apr 24, 2020Aug 11, 2020Oct 26, 2020Feb 24, 2021Apr 27, 2021Aug 13, 2021Oct 28, 2021Feb 28, 2022Apr 28, 2022Aug 19, 2022Oct 25, 2022Mar 24, 2023Apr 21, 2023Aug 18, 2023Oct 27, 2023Dec 31, 2023Apr 26, 2024Aug 27, 2024Oct 24, 2024Mar 29, 2025Apr 24, 2025Aug 23, 2025Oct 25, 2025Apr 24, 2026
EPS Estimate--------------------------0.120.18----0.39-0.44-0.10-0.14-0.140.13------
EPS Actual0.070.030.060.140.080.060.070.060.110.110.070.120.130.010.030.050.030.140.030.090.130.100.090.160.200.160.140.230.270.300.701.510.670.800.540.200.06-0.32-0.32-0.15-0.07-0.15-0.010.060.100.05
Surprise--------------------------16.67%27.78%----71.79%-22.73%--40.00%-128.57%-128.57%-215.38%------
Timing-Pre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hours-Pre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursPre-market-Pre-market---

Key Statistics & Ratios

Market Cap13.35B
Enterprise Value13.87B
Trailing P/E0.00
Forward P/E0.00
Price / Sales3.72
Price / Book2.77
EPS-0.28
Book Value9.24
Revenue (TTM)3.59B
Gross Profit (TTM)1.13B
EBITDA529.62M
Profit Margin-4.32%
Operating Margin8.02%
Return on Equity-4.16%
Return on Assets1.42%
Shares Outstanding543.44M
Shares Float311.55M
Beta0.52
Dividend Yield0.37%
Dividend Rate0.09
Payout Ratio60.44%

Dividends

20261×
0.09May 12, 2026
20241×
0.49May 29, 2024
20231×
1.11May 9, 2023
20221×
0.19Apr 28, 2022
20211×
0.12Apr 15, 2021
20201×
0.10May 8, 2020
20191×
0.05Jun 12, 2019
20181×
0.03May 18, 2018
20171×
0.06Apr 10, 2017
20161×
0.04Apr 25, 2016
20151×
0.03Mar 26, 2015
20141×
0.02Jun 18, 2014

Stock Splits

  • Sep 29, 201515:10
  • Mar 26, 201525:10